FORCEFIELD THERAPEUTICS LIMITED
Research and experimental development on biotechnology
FORCEFIELD THERAPEUTICS LIMITED
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
8 Bloomsbury Street London WC1B 3SR England
Full company profile for FORCEFIELD THERAPEUTICS LIMITED (12983133), an active life sciences and medical technology company based in London, England. Incorporated 29 Oct 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2021–2024)
Cash in Bank
£2.41M
Net Assets
£2.48M
Total Liabilities
£649.72k
Turnover
N/A
Employees
5
Debt Ratio
21%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2023 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
No fundraising or grants recorded
Investors (0)
No investor information available
Officers
Officers
| Status | |||||||
|---|---|---|---|---|---|---|---|
No officers found | |||||||
No officers found
See all 9 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (1)
Syncona Limited
British Channel Islands
- Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Mauro Giacca
Ceased 14 Jun 2021
Group Structure
Group Structure
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 2 Feb 2026 | Officers | Termination of John Tsai as director on 2026-01-31 | |
| 22 Oct 2025 | Confirmation Statement | Confirmation statement made on 2025-10-21 with updates | |
| 22 Sept 2025 | Accounts | Annual accounts made up to 2024-12-31 | |
| 9 Sept 2025 | Capital | Allotment of shares (GBP 92.49537) on 2025-08-06 | |
| 15 Aug 2025 | Resolution | Resolutions |
Termination of John Tsai as director on 2026-01-31
Confirmation statement made on 2025-10-21 with updates
Annual accounts made up to 2024-12-31
Allotment of shares (GBP 92.49537) on 2025-08-06
Resolutions
Recent Activity
Latest Activity
Termination of John Tsai as director on 2026-01-31
2 months ago on 2 Feb 2026
Confirmation statement made on 2025-10-21 with updates
6 months ago on 22 Oct 2025
Annual accounts made up to 2024-12-31
7 months ago on 22 Sept 2025
Allotment of shares (GBP 92.49537) on 2025-08-06
7 months ago on 9 Sept 2025
Resolutions
8 months ago on 15 Aug 2025